Top

Published in:

01-04-2016 | Case report

A case report of recurrent adult-onset xanthogranuloma: is the radiotherapy a treatment option?

Authors: R. Chicas Sett, O. Pons Llanas, F. Celada Álvarez, A. Pacheco Usmayo, S. Roldán, E. Collado, E. Cuervo Madrid, A. Solves Aleman, J. Pérez Calatayud, A. Tormo Micó

Published in: International Cancer Conference Journal | Issue 2/2016

Abstract

Adult-onset xanthogranuloma (AOX) is one of the four uncommon syndromes called adult xanthogranulomatous disease (AXD), which is diagnosed by characteristic histopathology. AXD is rare and heterogeneous group of entities that can affect multiple organ systems. Orbital involvement is included in the xanthogranulomatous disease although less prevalent. This work focuses on the use of external beam radiotherapy in the control of local symptoms of periocular manifestation of AOX as case report and literature review.

Chester W (1930) Über lipidgranulomatose. Virchows Archiv 279:561–602CrossRef

Hoffman E, Müller-Forell W, Pitz S, Radner H (2004) Erdheim–Chester disease: a case report. Graefe’s Arch Clin Exp Ophthalmol 242:803–807CrossRef

Sivak-Callcot J, Rootman J, Rasmussen S et al (2006) Adult xanthogranulomatous disease of the orbit and ocular adnexa: new inmunohistochemical findings and clinical review. Br J Ophthalmol 90:602–608CrossRef

Babu RP, Lansen TA, Chadburn A et al (1997) Erdheim–Chester disease of the central nervous system: report of two cases. J Neurosurg 86:888–892CrossRefPubMed

Veyssier-belot C, Cacoub P, Caparros-Lefebvre D et al (2001) Erdheim–Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine 75:157–169CrossRef

Martinez R (1995) Erdheim–Chester disease. MR of intraaxial and extraaxial brain stem lesions. AJNR Am J Neuroradiol 16:1787–1790PubMed

Masalchi M, Nencini P, Nistri M et al (2000) Failure of radiation therapy for brain involvement in Erdheim–Chester disease. J. Neurooncol 59:169–172CrossRef

Shamburek RD, Brewer HB, Caparros-Lefevre D et al (1996) Erdheim–Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine 75:157–169CrossRef

mazor RD, Manevich-Mazor M, Shoenfeld Y (2013) Erdheim–Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis 8:137CrossRefPubMedPubMedCentral

10.

Katsunori M, Yasushi N, Masahiro H (2007) Radiotherapy for Erdheim–Chester disease. Int J Clin Oncol 12:238–241CrossRef

11.

Miller R, Villá S, Kamer S et al (2006) Palliative treatment of Erdheim–Chester disease with radiotherapy: a rare cancer network study. Radiother Oncol 80:323–326CrossRefPubMed

12.

Aster JC, Pozdnyakova O, Kutok JL (2013) Hematopathology: a volume in the hight yield pathology series. Saunders, Elsevier, Amsterdam, pp 87–88

13.

Bohlega S, Alwatban J, Tulbah A et al (1997) Cerebral manifestation of Erdheim–Chester disease: Clinical and neurologic findings. Neurology 49:1702–17058CrossRefPubMed

14.

Kujat C, Martin J, Püschel W (1991) Erdheim–Chester disease. Radiology 31:297–306

15.

Wright RA, Hermann RC, Parisis JE (1999) Neurological manifestation of Erdheim–Chester disease. J Neurol Neurosurg Psychiatry 66:72–75CrossRefPubMedPubMedCentral

Title: A case report of recurrent adult-onset xanthogranuloma: is the radiotherapy a treatment option?
Authors: R. Chicas Sett
O. Pons Llanas
F. Celada Álvarez
A. Pacheco Usmayo
S. Roldán
E. Collado
E. Cuervo Madrid
A. Solves Aleman
J. Pérez Calatayud
A. Tormo Micó
Publication date: 01-04-2016
Publisher: Springer Japan
Published in: International Cancer Conference Journal / Issue 2/2016
Electronic ISSN: 2192-3183
DOI: https://doi.org/10.1007/s13691-015-0232-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2016

Primary diffuse large B cell lymphoma of the common bile duct causing obstructive jaundice

Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma

Cryptogenic repetitive severe colitis after ileostomy closure

Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer—report of 4 cases

Spontaneously metachronous ruptures of adrenocortical carcinoma and its contralateral adrenal metastasis

Colon cancer chemotherapy for a patient with CDX2-expressing metastatic thymic adenocarcinoma: a case report and literature review

Keynote webinar | Spotlight on antibody–drug conjugates in cancer